One Neurological Factor Keeps Black, Hispanic Patients From Alzheimer’s Clinical Trials
FRIDAY, April 19, 2024 (HealthDay News) — Black and Hispanic patients with Alzheimer’s disease are greatly underrepresented in clinical trials, even though they’re more likely to get dementia than whites. However, racial discrimination may not be driving this disparity, a new study finds. Instead, Black and Hispanic people are beingContinue Reading